Dataset Information
ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [methylation 850K]
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA548634 | ENA |
REPOSITORIES: ENA